Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NTQ1062 (compound 22b) is an orally active and potent Akt inhibitor that acts on Akt1 (IC50: 0.4 nM), Akt2 (IC50: 6.3 nM) and Akt3 (IC50: 0.1 nM). NTQ1062 showed significant anti-tumor effects in the LNCap xenograft tumor mouse model.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 2,140.00 | |
50 mg | 10-14 weeks | $ 2,785.00 | |
100 mg | 10-14 weeks | $ 3,520.00 |
Description | NTQ1062 (compound 22b) is an orally active and potent Akt inhibitor that acts on Akt1 (IC50: 0.4 nM), Akt2 (IC50: 6.3 nM) and Akt3 (IC50: 0.1 nM). NTQ1062 showed significant anti-tumor effects in the LNCap xenograft tumor mouse model. |
Molecular Weight | 483.01 |
Formula | C25H31ClN6O2 |
CAS No. | 2459489-66-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NTQ1062 2459489-66-6 inhibitor inhibit